Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

NCT02471196 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
308
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Orion Corporation, Orion Pharma

Collaborators